CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population

CompletedOBSERVATIONAL
Enrollment

1,031

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Colorectal CancerAdenomatous Polyp of ColonPolypsOther Disease/InjuryOther Cancers
Trial Locations (4)

Unknown

Beijing Cancer Hospital, Beijing

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

General Hospital of Beijing PLA Military Region, Beijing

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

collaborator

General Hospital of Beijing PLA Military Region

OTHER

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Peking University Cancer Hospital & Institute

OTHER

lead

BioChain (Beijing) Science and Technology, Inc.

INDUSTRY

NCT02540850 - CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population | Biotech Hunter | Biotech Hunter